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Objectives. Patients with aortic aneurysms have significant comorbidities which influence outcome. Our practice includes
comprehensive assessment to identify comorbidities, allowing subsequent medical optimisation prior to aneurysm repair.
The aim of this study was to assess this process and to identify any factors predictive of outcome.
Design. Prospective observational study.
Materials. Medical case notes of 200 patients referred with aortic pathology.
Methods. Data analysed included preoperative, perioperative and postoperative factors. Multiple logistic regression anal-
ysis was performed to identify predictors of outcome.
Results. Following assessment 17 patients (8.5%) were found to be unfit for intervention and 165 patients (82.5%)
proceeded to aneurysm repair. In this group assessment uncovered previously undiagnosed cardiac, respiratory and renal
comorbidity in 19%, 57% and 29% of patients respectively. Multiple logistic regression analysis indicated that optimisa-
tion by a renal physician reduced post-operative renal impairment (OR 0.12, 95% CI 0.03e0.45, P¼ 0.002) while opti-
misation by a cardiologist reduced respiratory complications (OR 0.7, 95% CI 0.05e0.99, P¼ 0.049). An abnormal
echocardiogram was associated with pneumonia (OR 6.9, 95% CI 1.6e29, P¼ 0.01) and death (OR 7.9, 95% CI
1.15e54, P¼ 0.036).
Conclusion. Pre-operative assessment identifies previously undiagnosed comorbidity in a significant proportion of
patients. Subsequent medical optimisation may reduce post-operative morbidity and mortality.
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The majority of patients with aortic aneurysms are
elderly with multiple co-morbidities, and as a result
are high-risk surgical candidates.1 This is reflected
by complication rates of approximately 30% following
conventional elective abdominal aortic aneurysm
(AAA) repair.2,3 Mortality is principally due to cardiac
causes, accounting for up to one half of all deaths.4e6
Respiratory complications comprise the second com-
monest cause of death,4 and renal dysfunction has
been associated with high mortality.7
Modification of risk factors that can be identified
preoperatively may improve outcome for these
patients.1 Methods available to stratify surgical risk
include history and examination, combined with in-
vestigations that aim to assess physiological reserve
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ulation of cardiac risk factors has formed the focus of
the majority of studies regarding morbidity and mor-
tality in elective aortic aneurysm repair, the presence
of pulmonary disease and renal impairment should
not be overlooked.1
It is our practice to pass all patients referred with
aortic pathology through a comprehensive assessment
and optimisation regime. This aids decision making
for the surgeon, improves informed consent for the
patient and identifies risk factors that can be modified
prior to aneurysm repair. This study was designed to
evaluate how effective this process is in identifying
undiagnosed comorbidity, the effect on morbidity
and mortality, and to identify any factors that may
predict outcome.
Materials and Methods
This was a prospective observational study of 200
patients referred for elective aneurysm repair bet-
ween January 2003 and June 2005. The followingrved.
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was collected from patients notes using a standardised
data collection form, and subjected to multivariate
stepwise logistic regression analysis.
Preoperative data consisted of age, sex, aneurysm
type, medical and drug history, smoking status, body
mass index (BMI) and American Society of Anesthesi-
ologists (ASA) grade. All patients were subject to a
standard assessment and optimisation protocol which
consisted of history and examination, routine blood
tests, resting electrocardiogram (ECG), static echocar-
diogram, arterial blood gases (ABGs), pulmonary
function tests (PFTs) and an axial CT scan of the aorta.
ECGs were considered abnormal if they displayed
ischaemic changes (Q waves or ST segment abnormal-
ities), rhythm abnormalities or conduction defects.
An abnormal echocardiogram was defined as one
demonstrating left ventricular dilatation or hypertro-
phy, impaired systolic function, regional wall motion
abnormalities or aortic stenosis. PFTs were considered
abnormal if they revealed an forced expiratory volume
in 1 second (FEV1) of less than 80% of that predicted
(British Thoracic Society COPD Guidelines 2004).
ABGs were considered abnormal if they revealed
hypoxia (PO2< 8 kPa), or hypercarbia (PCO2> 7 kPa).
Serum creatinine was used as a surrogate marker of
renal function and was defined as abnormal if it was
above 110 mmol/L. Subsequent referral to a medical
specialist was guided by the results of the assessment
and the outcome of the referral was recorded.
Perioperative data consisted of anaesthetic type,
length of operation, blood loss, and duration of ITU
stay. Postoperative outcomes consisted of complica-
tions and death.
Statistical analysis
Continuous variables were not normally distributed
and therefore expressed as medians with interquartile
range (IQR). Discrete variables were expressed as
numbers and percentages. We investigated the associ-
ation between the preoperative and perioperative var-
iables and complications and death using multivariate
stepwise logistic regression, in order to identify any
independent predictors of complications and death.
A P-value of less than 0.05 was considered statistically
significant. Statistical analysis was performed utilis-
ing SPSS 12.0 software (SPSS, Inc., Chicago, IL).
Results
Following assessment 165 of the 200 patients referred
proceeded to aneurysm repair. There were 140abdominal aortic aneurysm repairs, of which 33
were open (OAAA) and 107 were endovascular
(EVAR). Seventeen thoracic aneurysms (TA) all under-
went endovascular repair and 8 thoraco-abdominal
aneurysms (type IV) all underwent open repair. Sev-
enteen patents were found to be unfit for intervention
(12 AAA, 3 TA, 2 type-IV). A further 18 patients didn’t
receive intervention for other reasons; entered surveil-
lance programmes (7), patient refused intervention
(5), death prior to repair (3), conservative arm of
EVAR 2 trial (2), patient returned to referring hospital
(1). Unless otherwise stated the following data refer to
those patients that underwent aneurysm repair.
Known comorbidity
It can be seen that the extent of known comorbidity
prior to assessment was considerable (Table 1). There
was a history of cardiac disease in 63.6% of patients.
This included 53.3% with coronary artery disease
(angina 32.7%, previous myocardial infarction 39.4%,
previous coronary artery bypass graft 15.8% or angio-
plasty 7.3%). In addition to statins, b-blockers and
aspirin, 74.5% of patients took additional cardiac
medications (calcium channel blockers, diuretics,
Table 1. Demographics and known comorbidity prior to
assessment
Parameter Number or median
(IQR) (n¼ 165)
Percentage
or range
Demographics
Age 74 (68e78) 43e91
Gender - Male 147 89.1%
Aneurysm type
Abdominal aortic
aneurysm
140 84.8%
Thoracic aneurysm 17 10.3%
Type IV thoraco-
abdominal aneurysm
8 4.8%
Known co-morbidity
Cardiac disease 105 63.6%
Coronary artery disease 88 53.3%
Arrhythmia 25 15.2%
Left ventricular failure 21 12.7%
Hypertension 121 73.3%
Diabetes 26 15.8%
CVA/TIA 22 13.3%
Respiratory disease
Chronic Obstructive
Pulmonary Disease
40 24.2%
Smoking history 146 88.5%
Renal disease 26 15.8%
Medications
Statin 148 89.7%
Anti-platelet 137 83.0%
Beta-blocker 70 42.4%
Other cardiac medications 123 74.5%Eur J Vasc Endovasc Surg Vol 33, January 2007
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patients taking more than two medications. A quarter
of patients had a previous diagnosis of chronic obstruct-
ive airways disease (COPD), under the care of either
a hospital or primary care physician. Sixteen percent of
patients had a prior history of chronic renal impairment.
Results of assessment
BMI measurement revealed that 62.7% of patients
were overweight or obese (BMI> 24.9 kg/m2).
Patients of ASA grade 3e4 comprised 87.9% with
only 12.1% ASA grade 2. The ECG was abnormal in
52.3% with a combination of ischaemic, conduction
and rhythm abnormalities. The echocardiogram was
abnormal in 60.4% with left ventricular dilatation
present in 20.1%, left ventricular hypertrophy present
in 16.2%, systolic dysfunction present in 26%, regional
wall motion abnormalities present in 36.4% and aortic
stenosis in 9.1%. Pulmonary function tests revealed
COPD in half of the patients, and ABGs were abnor-
mal in 59% (55.5% with hypoxia and 7.2% with hyper-
carbia). Renal impairment was detected in 41.2% of
patients. In the patients that were deemed unfit for
aneurysm repair the burden of disease was even
higher, with a greater proportion of abnormal results
in all investigations.
Effect of assessment
As a result of assessment previously undiagnosed car-
diac comorbidity was revealed in 19% of patients,
respiratory comorbidity in 57% and renal comorbidity
in 29% (Fig. 1). Following assessment the total percent-
age of patients with identified cardiac disease was
83%, respiratory disease 81%, and renal disease 45%.
Optimisation
Forty four percent of cases were referred to a cardiolo-
gist, 32% to a respiratory physician and 16% to a renal
physician. The patients referred to a cardiologist
included those with newly-diagnosed cardiac disease
and those with symptoms suggesting unstable disease.
The remaining patients with cardiac disease that were
not referred had known stable disease and had previ-
ously been reviewed by a cardiologist prior to assess-
ment. Of the cardiology referrals, 55% resulted in a
change in management (75% change in medications,
23% referred for CABG or coronary stent, 2.5%
referred for pacemaker). Of the respiratory referrals
63% resulted in a change of management, all consist-
ing of medication changes. Of the renal referrals,Eur J Vasc Endovasc Surg Vol 33, January 200723% resulted in a change of management (50% drug
change, 50% planned peri-operative dialysis).
Perioperative factors
Perioperative data included in the regression analysis
are shown in Table 2.
Morbidity and mortality
Cardiac complications occurred in 14.5% (9.7% acute
coronary syndrome and 4.8% left ventricular failure).
Respiratory complications occurred in 12.1% (8.5%
pneumonia and 3.6% respiratory failure) and renal
failure occurred in 9% with no long-term dialysis
requirement or death. Other complications included
bowel ischaemia (1.2%) and cerebrovascular accident
(1.2%). In total there were 6 deaths due to myocardial
infarction, bronchopneumonia, cerebrovascular acci-
dent, ischaemic heart disease, small bowel infarction
and septicaemia. The mortality was distributed as
follows: 1/33 OAAA (3.0%), 4/107 EVAR (3.7%) and
1/8 type-IV (12.5%). Observed mortality compared
favourably to P-POSSUM predicted mortality for both
open and endovascular infra-renal aneurysm repair
(3.0% vs 8.3% and 3.7% vs 8.1% respectively). As
P-POSSUM scoring has not been validated in supra-
renal aneurysm repair comparisons were not made
in these groups.
Multiple logistic regression analysis
Multiple regression analysis indicated that an abnor-
mal echocardiogram was associated with post-
operative pneumonia (OR 6.9, 95% CI 1.6e29, P¼ 0.01)
Fig. 1. Graph demonstrating proportion of newly diagnosed
comorbidity uncovered by assessment in patients undergo-
ing aneurysm repair.
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Pre-operative intervention by a renal physician was
associated with a reduction in post-operative renal
impairment (OR 0.12, 95% CI 0.03e0.45, P¼ 0.002)
and pre-operative intervention by a cardiologist was
associated with a reduction in respiratory complica-
tions (OR 0.7, 95% CI 0.05e0.99, P¼ 0.049).
Discussion
Mortality rates associated with aneurysm repair do
not take into consideration the effect of pre-existing
risk factors.6 The identification of modifiable risk fac-
tors provides the opportunity formedical optimisation,
whichmay improve functional deficits associated with
perioperative death.8 Methods available to stratify sur-
gical risk include a history and examination, combined
with investigations that aim to assess physiological
reserve and identify underlying pathology.8 Angina,
heart failure and a previous history of myocardial
infarction have all been associated with increased peri-
operative death.6e8 Similarly, ECG evidence of ischae-
mic heart disease or ventricular ectopics have also
been associated with increased risk.6 Ejection fraction
measurements using echocardiograms have been
used to define high-risk patients.9 Low FEV1 has been
strongly associated with postoperative mortality,10
and exercise capacity has shown a clear effect onmortal-
ity.6 Renal dysfunction and elevated serum creatinine
has been associated with postoperative mortality fol-
lowing elective AAA surgery.7,8,10 Our system is there-
fore based around these discriminatory investigations.
Table 2. Perioperative factors
Parameter Number or median
(IQR) (n¼ 165)
Percentage
or range
Anaesthetic type
General 147 89.1%
Regional 18 10.9%
Length of Operation (hours)
0e1.9 18 10.9%
2e3.9 106 64.2%
4e5.9 38 23.0%
>6 3 1.8%
Blood loss (litres)
0e0.9 127 77.0%
1.0e1.9 18 10.9%
2.0e2.9 11 6.7%
3.0e3.9 7 4.2%
>4.0 2 1.2%
ITU stay (days)
AAA e open (n¼ 33) 2.0 (2.0e4.5) 1e13
AAA e endovascular
(n¼ 107)
0.0 (0.0e1.0) 0e8
TA e endovascular (n¼ 17) 0.0 (0.0e3.0) 0e5
Type IV e open (n¼ 8) 3.0 (2.5e3.5) 1e5With the growing evolution of endovascular tech-
niques, minimally invasive aneurysm repair has
become established in many centres. Although poten-
tially associated with reduced morbidity and mortal-
ity, we would now consider endovascular repair in
patients previously deemed unfit for open repair.
This is a tertiary referral centre which attracts patients
with complex aneurysm disease and those deemed
unfit for repair. The 30 day mortality rate following
EVAR of AAA in this study (3.7%) allows us to con-
tinue to consider ‘unfit’ patients for endovascular re-
pair, despite the results of the EVAR 2 trial (9% 30
day mortality). However, we continually audit this
practice. This study highlights the burden of disease
in this cohort of patients, and the necessity for medi-
cal optimisation to improve morbidity and mortality.
Vascular surgeons that carry out high volume
surgery are more aggressive in their assessment of
cardiac risk prior to reconstruction,11 but it would
seem that assessment is generally not comprehensive.
Although 93% of surgeons routinely carry out
blood tests,1 routine ECG occurred in only 68%,1
with routine echocardiograms being performed in
25e47%.1,6,11 One possible concern is the cost-
effectiveness of such an intensive preoperative opti-
misation package. However this must be balanced
by the potential reduction in ITU stay, morbidity
and mortality. It has been suggested that stress echo-
cardiogram should replace static echocardiogram as
a superior investigation for revealing underlying car-
diac dysfunction prior to surgery. This is a matter for
discussion, and our protocol is flexible, reserving cer-
tain investigations for select groups, such as dynamic
cardiac studies in those patients undergoing open
thoracic surgery, or following recommendation from
a cardiologist. Another possible criticism of this opti-
misation regime is that it may delay aneurysm repair.
In our unit a system has been developed with a vascu-
lar nurse practitioner in which all investigations are
carried out in one day. If intervention is required by
a specialist patients are kept in overnight. With this
system we have not experienced any delay in aneu-
rysm repair.
This study has demonstrated that patients deemed
unfit for intervention have much worse cardiorespira-
tory function. But how is ‘fitness for intervention’
assessed? We use a multi-disciplinary team approach
involving surgeons, anaesthetists and intensivists. We
base our decision on the multiple data uncovered by
the assessment and optimisation process. Therefore,
due to the individually tailored approach it is very
difficult to construct a protocol to decide who is unfit
for intervention. This may explain why 85% of vascu-
lar surgeons were found not to use any form ofEur J Vasc Endovasc Surg Vol 33, January 2007
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renal AAA repair.1
Limitations of study
One potential criticism is that this series contains
mixed pathologies of the aorta and different interven-
tion modalities, which may lead to a wide variation of
complication rates. We included all patients referred
for aortic surgery because every patient is initially
treated identically by being subjected to the same
assessment and optimisation regime. We found that
patients with mixed aortic disease had similar pre-
operative comorbidities irrespective of specific pathol-
ogy, and the inclusion of all patients highlights the
impact of optimisation within our normal working
practice.
Another possible criticism is the inclusion of
patients that were part of the EVAR trials, as treatment
decisions may be based on randomisation and not
clinical background. Twenty patients were recruited
into EVAR 1, and the decision to operate was based
on the assessment and optimisation regime, in the
same way as non-trial patients, with only the treat-
ment modality being subject to randomisation. Seven
patients underwent aneurysm repair as part of the
EVAR 2 trial. Due to advances in EVAR techniques
these patients are representational of the other
patients with significant comorbidity included in the
study that we now consider suitable for EVAR. This
is corroborated by the fact that 88% of all our patients
were ASA 3e4.
Conclusion
Our practice allows us to identify previously undiag-
nosed, significant co-morbidity in a large proportion
of patients. It identifies unfit candidates aiding patient
selection and allows for targeted medical optimisation
of modifiable risk factors in surgical candidates.
Optimisation may be associated with a reduction inEur J Vasc Endovasc Surg Vol 33, January 2007post-operative complications resulting in satisfactory
mortality rates.
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